Fareva Amboise

France
Oral Solid Dose Semi-solids & Liquids
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1) ○ Clinical Trials ○ SEC Filings ○ Press ✓ EMA GMP (3) ○ MHRA GMP ✓ HC GMP (9)

Quick Facts: Fareva Amboise

Signal Score
Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters
France
Website
Modalities
Oral Solid Dose, Semi-solids & Liquids
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About Fareva Amboise

Fareva Amboise is a contract development and manufacturing organization (CDMO). Capabilities: Oral Solid Dose, Semi-solids & Liquids. 1 manufacturing site registered with the U.S. FDA and Health Canada. Website: https://www.fareva.com/

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

Fareva Amboise FDA Inspection History

2025-09
NAI VAI OAI
Date Site Type Observations Classification
2025-09-16
Fareva Amboise
Poce Sur Cisse Company-level
Drug Quality Assurance Yes Official Action Indicated (OAI)
Source: FDA Data Dashboard · Retrieved Oct 31, 2026

Fareva Amboise FDA 483 Findings 9 observations · 2025-09-16 → 2025-09-16 ?

By subsystem

  • Documentation & Records 4 (44.4%)
  • Environmental Monitoring 3 (33.3%)
  • Equipment & Facilities 1 (11.1%)
  • Data Integrity 1 (11.1%)

By severity

  • 5 — Critical: 1
  • 4 — Serious: 3
  • 2 — Minor: 5
  • Repeat observations: 0

Most severe findings

  • Critical (5) Data Integrity 2025-09-16 21 CFR 211.68(b)
    Computer control of master formula records

    "Appropriate controls are not exercised over computers or related systems to assure that changes in master production and control records or other records are instituted only by authorized personnel."

  • Serious (4) Environmental Monitoring 2025-09-16 21 CFR 211.113(b)
    Validation lacking for sterile drug products

    "Procedures designed to prevent microbiological contamination of drug products purporting to be sterile did not include adequate validation of the aseptic process."

  • Serious (4) Environmental Monitoring 2025-09-16 21 CFR 211.42(c)(10)(iv)
    Environmental Monitoring System

    "Aseptic processing areas are deficient regarding the system for monitoring environmental conditions."

Fareva Amboise EMA GMP Compliance 3 certificates

2025-10
2025-10
2025-04
Compliant Non-Compliant
Certificate Site Country Inspection Date Status
2026_HPF_FR_007 Fareva Amboise France 2025-10-02 COMPLIANT
2026_HPF_FR_008 Fareva Amboise France 2025-10-02 COMPLIANT
25/389926 Fareva Amboise France 2025-04-30 COMPLIANT
Source: EMA EudraGMDP · Retrieved Oct 31, 2026

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Oct 30, 2026

Frequently Asked Questions About Fareva Amboise

How many FDA inspections does Fareva Amboise have on record?
CDMO Signal tracks 1 FDA inspection for Fareva Amboise, sourced from the FDA inspection database. See the full inspection history above.
Has Fareva Amboise received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Fareva Amboise.
Does Fareva Amboise hold EMA or MHRA GMP certificates?
CDMO Signal tracks 3 EMA GMP certificates for Fareva Amboise.
Does Fareva Amboise have a CDMO Signal Score?
Not yet. Fareva Amboise is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Fareva Amboise for a manufacturing program?
Use the free AI matchmaker to compare Fareva Amboise against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.

Similar CDMOs

Pierre Fabre CDMO
Castres, France
Oral Solid Dose, Finished Dosage Forms, Non-sterile Liquids, Semi-solids & Liquids, Small Molecule API, High-Potency APIs, Packaging & Labeling
Laboratoire Unither
France
Sterile Fill-Finish, Semi-solids & Liquids, Oral Solid Dose
Vetio Animal Health
United States
Oral Solid Dose, Semi-solids & Liquids, Sterile Fill-Finish
Contract Pharmacal Corp.
Hauppauge, New York, USA
Oral Solid Dose, Semi-solids & Liquids
Halo Pharmaceutical Canada
Mirabel, Quebec, Canada
Oral Solid Dose, Semi-solids & Liquids

Compare Fareva Amboise with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Fareva Amboise
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.